Green Valley Pharmaceuticals Overview
- Year Founded
-
1996
- Status
-
Acquired/Merged
- Employees
-
1,500
- Latest Deal Type
-
M&A
- Financing Rounds
-
2
- Investments
-
1
Green Valley Pharmaceuticals General Information
Description
Developer of pharmaceuticals intended to pioneer carbohydrate drug development and new treatment strategies in the areas of chronic and complex diseases. The company focuses on the research and development of sugar drugs, builds a brain platform, and contributes to patients around the world and develops a health program with brain health as its core value, thereby helping in restoring the quality of life for more patients and their families afflicted by Alzheimer's disease and other diseases.
Contact Information
Website
www.greenvalleypharma.com(Operating Subsidiary)
Corporate Office
- Number 421 Newton Road, China Free Trade Zone
- Shanghai
- China
Corporate Office
- Number 421 Newton Road, China Free Trade Zone
- Shanghai
- China
Green Valley Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Green Valley Pharmaceuticals Patents
Green Valley Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2021249503-A1 | Disaccharide exo-type β-mannan hydrolase and application thereof | Inactive | 10-Jun-2020 | ||
| WO-2021233314-A1 | Methods for preparing β-d-(1,4)-mannuronate oligosaccharide and intermediate thereof | Inactive | 19-May-2020 | ||
| AU-2020377024-A1 | Pharmaceutical composition containing alginate oligosaccharide diacid | Active | 31-Oct-2019 | ||
| AU-2020377024-B2 | Pharmaceutical composition containing alginate oligosaccharide diacid | Inactive | 31-Oct-2019 | ||
| EP-4052711-A1 | Pharmaceutical composition containing alginate oligosaccharide diacid | Inactive | 31-Oct-2019 | A61K31/734 |
Green Valley Pharmaceuticals Signals
Green Valley Pharmaceuticals Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Green Valley Pharmaceuticals Investments (1)
Green Valley Pharmaceuticals’s most recent deal was a Early Stage VC with JiSiMingZhi for . The deal was made on 02-Feb-2021.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| JiSiMingZhi | 02-Feb-2021 | Early Stage VC | Diagnostic Equipment |
Green Valley Pharmaceuticals FAQs
-
When was Green Valley Pharmaceuticals founded?
Green Valley Pharmaceuticals was founded in 1996.
-
Where is Green Valley Pharmaceuticals headquartered?
Green Valley Pharmaceuticals is headquartered in Shanghai, China.
-
What is the size of Green Valley Pharmaceuticals?
Green Valley Pharmaceuticals has 1,500 total employees.
-
What industry is Green Valley Pharmaceuticals in?
Green Valley Pharmaceuticals’s primary industry is Drug Discovery.
-
Is Green Valley Pharmaceuticals a private or public company?
Green Valley Pharmaceuticals is a Private company.
-
What is the current valuation of Green Valley Pharmaceuticals?
The current valuation of Green Valley Pharmaceuticals is .
-
What is Green Valley Pharmaceuticals’s current revenue?
The current revenue for Green Valley Pharmaceuticals is .
-
Who are Green Valley Pharmaceuticals’s investors?
Shanghai Institute of Materia Medica has invested in Green Valley Pharmaceuticals.
-
When was Green Valley Pharmaceuticals acquired?
Green Valley Pharmaceuticals was acquired on 23-Jan-2026.
-
Who acquired Green Valley Pharmaceuticals?
Green Valley Pharmaceuticals was acquired by Fosun Pharma.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process